Richard Kaufman is a partner and corporate lawyer with Foley & Lardner LLP where his practice includes structuring and negotiation of strategic partnerships and collaborations, technology transfers and licenses, spin-out transactions, manufacturing agreements, and clinical research agreements, as well as engagements for financings, mergers, acquisitions, and divestitures. He is managing partner of the San Diego office and is former vice chair of the firm’s Private Equity & Venture Capital Practice, co-chair of the Life Sciences Industry Team and a member of the Transactional & Securities Practice.

Mr. Kaufman has significant experience with a wide variety of corporate and securities transactions for companies in the life sciences industry, including developers of drugs, biologics, medical devices, and discovery and informatics tools.

For 14 years, Mr. Kaufman served as general counsel of public life sciences companies engaged in the development and manufacture of proteins, peptides, small molecules and medical devices, as well as predictive in silico drug discovery tools.

Mr. Kaufman was a partner with Heller Ehrman LLP before joining Foley in 2008. Prior to joining Heller Ehrman, Mr. Kaufman's in-house positions included general counsel to Trega Biosciences, Inc.; senior vice president, corporate development and law at Integra LifeSciences Corporation; vice president, secretary, and general counsel at Telios Pharmaceuticals, Inc.; and executive vice president, secretary, and general counsel at Invitron Corporation, a spin-off of Monsanto Company. Prior to moving in-house, Mr. Kaufman was a partner at Peper, Martin, Jensen, Maichel and Hetlage in St. Louis, Missouri, where he practiced for nine years. Previously, he served as a law clerk to the Honorable Robert E. Seiler, Chief Justice of the Missouri Supreme Court.